Kinetic of 3DO Apoptosis and Activation
Groups . | % Apoptosis . | Fas (median) . | FasL (%) . | IL-2 (pg/mL) . | IL2R+ (%) . |
---|---|---|---|---|---|
Control | 1.8 | 12.6 | 1.2 | Neg | Neg |
Anti-CD3 (1 h) | 2.1 | 13.1 | 2.2 | Neg | Neg |
Anti-CD3 (4 h) | 2.5 | 13.8 | 1.3 | Neg | Neg |
Anti-CD3 (8 h) | 7.5 | 16.5 | 9 | 106.4 | 25 |
Anti-CD3 (18 h) | 40 | 38.5 | 58.5* | 702 | 63 |
Groups . | % Apoptosis . | Fas (median) . | FasL (%) . | IL-2 (pg/mL) . | IL2R+ (%) . |
---|---|---|---|---|---|
Control | 1.8 | 12.6 | 1.2 | Neg | Neg |
Anti-CD3 (1 h) | 2.1 | 13.1 | 2.2 | Neg | Neg |
Anti-CD3 (4 h) | 2.5 | 13.8 | 1.3 | Neg | Neg |
Anti-CD3 (8 h) | 7.5 | 16.5 | 9 | 106.4 | 25 |
Anti-CD3 (18 h) | 40 | 38.5 | 58.5* | 702 | 63 |
3DO cells were cultured for different times in 96-well plates coated with anti-CD3 MoAb (1 μg/mL). Results are expressed as the percentage of apoptotic nuclei, the median of Fas expression histogram, the percentage of FasL+ cells, the amount of IL-2 in pg/mL, the percentage of IL-2R+ cells, and are the means of three separate experiments. The standard errors (<10%) are omitted for clarity.
Blocking peptide, at a concentration 10-fold higher then anti-FasL antibody was used, in two experiments, to control the specificity of the staining. Addition of the peptide inhibited the FasL staining down to 2.1% (first experiment) and 2.6% (second experiment), respectively, compared with anti-CD3 (18 h)-treated cells giving 57.2% (first experiment) and 58% (second experiment).